New Glaucoma Drop: A combination of Alphagan (brimonidine) and Carbonic Anhydrase inhibitor (like Trusopt: brinzolamide) Called Simbrinza
Simbrinza is a combination of brimonidine and brinzolamide. 1. It was FDA approved this week. 2. It is the only beta blocker–free, fixed-combination therapy for glaucoma available in the United States. 3. Simbrinza combines a carbonic anhydrase inhibitor (brinzolamide 1.0%) and an alpha 2 adrenergic receptor agonist (brimonidine tartrate 0.2%) in a single multidose bottle 4. For […]